This study investigated the role of PTBP2 in regulating CML pathology and found that it promotes cell proliferation through oxidative phosphorylation (OXPHOS) supported by mitochondrial fusion. Here, PTBP2 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.